Sky View Investment Advisors, LLC Pfizer Inc Transaction History

Sky View Investment Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 16, 2023	SELL	$32.09 - $37.51 $384,213 - $449,107	-11,973 Reduced 92.15%	1,020 $34,000
Q2 2023 Aug 15, 2023	SELL	$36.12 - $41.79 $140,904 - $163,022	-3,901 Reduced 23.09%	12,993 $477,000
Q1 2023 May 18, 2023	SELL	$39.39 - $51.28 $13,077 - $17,024	-332 Reduced 1.93%	16,894 $690,000
Q4 2022 Feb 16, 2023	SELL	$41.75 - $54.5 $110,595 - $144,370	-2,649 Reduced 13.33%	17,226 $883,000
Q3 2022 Nov 16, 2022	BUY	$43.76 - $53.42 $76,930 - $93,912	1,758 Added 9.7%	19,875 $870,000
Q2 2022 Nov 15, 2022	BUY	$46.53 - $55.17 $260,800 - $309,227	5,605 Added 44.8%	18,117 $950,000
Q1 2022 May 17, 2022	SELL	$45.75 - $56.69 $1,647 - $2,040	-36 Reduced 0.29%	12,512 $617,000
Q4 2021 Feb 18, 2022	SELL	$41.32 - $61.25 $224,202 - $332,342	-5,426 Reduced 30.19%	12,548 $781,000
Q3 2021 Nov 16, 2021	BUY	$39.25 - $50.42 $272,159 - $349,612	6,934 Added 62.81%	17,974 $773,000
Q1 2021 May 18, 2021	SELL	$33.49 - $37.77 $17,548 - $19,791	-524 Reduced 4.53%	11,040 $400,000
Q4 2020 Mar 02, 2021	BUY	$33.47 - $42.56 $387,047 - $492,163	11,564 New	11,564 $426,000

3,271

3.63B

74.3M

107M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Sky View Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sky View Investment Advisors, LLC with notifications on news.